Abnormal levels of serum lipids, specifically low HDL-C concentration, are associated with an elevated risk of both non-CVD and CVD mortality, with these relationships more pronounced in older participants and in persons with hypertension or diabetes.
Key Findings
Results
Higher HDL-C tertiles were associated with significantly lower risk of all-cause mortality compared to the lowest tertile after full adjustment.
Second tertile of HDL-C (37.9–45.8 mg/dL): HR=0.72, 95% CI: 0.57–0.92 for all-cause mortality
Third tertile of HDL-C (45.8–96.2 mg/dL): HR=0.81, 95% CI: 0.64–1.03 for all-cause mortality
Lowest tertile (≤37.9 mg/dL) served as the reference group
Model 3 was adjusted for BMI, smoking status, diabetes, hypertension, CVD, job, marital status, education level, and lipid-lowering drug use
Results
Individuals in the second HDL-C tertile had a significantly reduced risk of cardiovascular mortality after full adjustment.
Second tertile of HDL-C: HR=0.66, 95% CI: 0.46–0.94 for cardiovascular mortality
The third tertile did not reach statistical significance for cardiovascular mortality
This association was observed in a cohort of 9704 participants followed for approximately 10 years
Results
No significant associations were found between LDL-C and mortality after multivariable adjustment.
LDL-C was analyzed both as a continuous variable and categorized into tertiles
Adjustment included age, sex, BMI, smoking, diabetes, hypertension, CVD, job, marital status, education level, and lipid-lowering drug use
This finding applied to both all-cause mortality and cardiovascular mortality outcomes
Results
Kaplan-Meier analyses confirmed significant survival differences across tertiles of HDL-C, TG, and non-HDL-C for all-cause mortality.
HDL-C tertiles: P value = 0.005 for all-cause mortality
TG tertiles: P value = 0.001 for all-cause mortality
Non-HDL-C tertiles: P value < 0.001 for all-cause mortality
HDL-C survival curves also differed significantly for cancer mortality (P value = 0.048)
Results
Kaplan-Meier analyses showed significant differences in cardiovascular death survival curves for HDL-C and TG groups.
HDL-C groups: P value = 0.003 for cardiovascular mortality
TG groups: P value = 0.015 for cardiovascular mortality
Over the 10-year follow-up, there were 185 cases of CVD death out of 429 total deaths (4.4% of the cohort)
Results
The inverse correlation between elevated HDL-C levels and mortality was more pronounced in older individuals and those with hypertension or diabetes.
Subgroup analyses were performed to evaluate confounding variables related to serum lipid levels and mortality
The association was less significant in younger and healthier individuals
These patterns were described as 'substantially greater' in older participants and those with comorbidities
Methods
The study cohort consisted of 9704 individuals aged 35–65 years from the MASHAD study, followed for approximately 10 years.
The MASHAD (Mashhad Stroke and Heart Atherosclerotic Disorder) study was initiated in 2007
Over the follow-up period, there were 429 deaths (4.4%), including 185 CVD deaths and 124 cancer deaths
Multivariable Cox proportional hazards models were applied with three adjustment levels
Lipid variables (LDL-C, HDL-C, non-HDL-C, TG) were analyzed as continuous variables and in tertiles
Saberi-Karimian M, Mohammadi-Bajgiran M, Shabani N, Farsi F, Saffar Soflaei S, Farrokhzadeh F, et al.. (2026). Association of Serum Lipids with 10-Year CVD and All-Cause Mortality in Iranian Adults: A Prospective Cohort Study.. Archives of Iranian medicine. https://doi.org/10.34172/aim.34909